Found 57 matching trials
Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma PHASE2 The purpose of this study is to observe and evaluate the efficacy and safet...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects PHASE1 This is an open-label, non-randomized, dose escalation phase I trial to eva...
Show More Location
Cancer Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
A Study to Evaluate SHR-1210 in Subjects With Advanced HCC PHASE2 This a randomized controlled Phase 2/3 study to evaluate the efficacy and s...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer PHASE1 The purpose of this study is to observe and preliminary explore the efficac...
Show More Location
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
Cryoablation Combined with Anti-PD-1 Antibody in Patients with Advanced Intrahepatic Cholangiocarcinoma PHASE2 The objective of this study is to evaluate the efficacy and safety of cryoa...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC PHASE3 SHR-1210 is a humanized anti-PD1 IgG4 monoclonal antibody. This is a random...
Show More Location
Tongji University, Shanghai Pulmonary Hospital
Learn More & Join Trial
Study of Anti-PD-1 Antibody SHR-1210 Plus Apatinib vs SHR-1210 as Second-Line Treatment of Advanced Esophageal Squamous Cell PHASE3 The purpose of this study is to observe and evaluate the efficacy and safet...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC) PHASE2 This single arm, open label, single center, prospective study was designed ...
Show More Location
Beijing Union Medical College Hospital
Learn More & Join Trial